How GLP-1 Therapies Are Reshaping Coverage, Care Models, and MedTech Opportunities

Dive into the transformative potential of GLP-1 receptor agonists and their sweeping implications for MedTech. Explore how these groundbreaking obesity drugs are reshaping health outcomes, coverage policies, and therapeutic interventions, while presenting both challenges and opportunities for medical device manufacturers. Gain insights from industry experts on the evolving landscape of obesity care, the future of medical devices, and the strategic innovations needed to thrive in this dynamic environment. Discover how collaboration and a multifaceted approach can unlock new possibilities in the fight against obesity.